Septin 4 Inhibitors is a category of compounds that, while not directly inhibiting Septin 4, might influence its activity indirectly. These inhibitors can affect various cellular processes and signaling pathways, potentially influencing the role and function of Septin 4 within the cell. The diversity of these compounds showcases the complexity of cellular processes and the interconnectedness of various cellular components and pathways.
Consider the inhibitors that affect cytoskeletal dynamics, such as Blebbistatin, Nocodazole, and Latrunculin A. Blebbistatin is a selective inhibitor of non-muscle myosin II, a molecule crucial for the contractility of the actomyosin cytoskeleton. Changes in cytoskeletal dynamics due to Blebbistatin might indirectly impact Septin 4, as Septins are known to associate with the cytoskeleton. Nocodazole and Latrunculin A, on the other hand, depolymerize microtubules and actin filaments, respectively. Given that Septin 4 can interact with these cytoskeletal components, the disruption of these structures might indirectly influence Septin 4 function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
A selective inhibitor of non-muscle myosin II. It can affect cytoskeletal dynamics, which may indirectly influence Septin 4 due to its association with the cytoskeleton. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole is a microtubule-depolymerizing agent that may disrupt Septin 4's interaction with microtubules. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A is an actin-depolymerizing agent that may disrupt the interaction between Septin 4 and actin filaments. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is an inhibitor of protein transport from the endoplasmic reticulum to the Golgi apparatus, which may influence Septin 4's cellular localization and function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that may affect various signaling pathways, potentially influencing Septin 4 indirectly. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that may affect various signaling pathways, potentially influencing Septin 4 indirectly. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that potentially influences the MAPK/ERK pathway, possibly affecting Septin 4 indirectly. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may affect various signaling pathways, possibly influencing Septin 4 indirectly. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that may affect various signaling pathways, potentially influencing Septin 4 indirectly. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a Src family kinase inhibitor, which may influence multiple cellular processes and indirectly affect Septin 4. | ||||||